Long-term Follow-up Study to Evaluate Safety and Efficacy of FBX-101 in Krabbe Patients
Clinical trial NCT06308718 · TERMINATED
Trial details
- NCT number
- NCT06308718
- Sponsor
- Forge Biologics, Inc
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-06
- Primary completion
- 2025-04-10
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.